A Day Up For Kintara Therapeutics Inc.
Wed, Apr 03, 2024 at 07:15 PM
Kintara Therapeutics Inc. (KTRA:NASDAQ) shot up at $0.16, a gain of 63.3%. On Wed, Apr 03, 2024, KTRA:NASDAQ hit a New 2-Week High of $0.16. The stock appeared on our News Catalysts scanner on Wed, Apr 03, 2024 at 08:31 AM in the 'AGREEMENT' category. From Wed, Mar 20, 2024, the stock recorded 44.44% Up Days and 10.00% Green Days
The stock spiked on Wed, Apr 03, 2024 at $0.24 with a volume of 222M+.
About Kintara Therapeutics Inc. (KTRA:NASDAQ)
Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs.
Top 10 Gainers:
- ARCA biopharma, Inc. (ABIO:NASDAQ), 90.06%
- two Class A (TWOA:NYSE), 71.47%
- Kintara Therapeutics Inc. (KTRA:NASDAQ), 63.35%
- Mediaco Holding Inc. (MDIA:NASDAQ), 52.33%
- Aurora Cannabis Inc. (ACB:NASDAQ), 44.06%
- Aesthetic Medical International Holdings Group Limited (AIH:NASDAQ), 43.75%
- StoneBridge Acquisition Corporation (APAC:NASDAQ), 43.03%
- Yield10 Bioscience, Inc. (YTEN:NASDAQ), 41.41%
- OneMedNet Corp. (ONMD:NASDAQ), 34.13%
- Asensus Surgical Inc. (ASXC:NYSEMKT), 33.55%